November 5, 2024 C-Path Scientific Directors Belmonte, Kosinski to Present at 20th IDS Congress Paul Belmonte, C-Path’s Scientific Director, T1D Consortium, and Luke Kosinski, Director, Quantitative Medicine, will present...
September 30, 2024 TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction...